|
GB202016822D0
|
|
Quantitation of immunoglobulins in mass spectrometry
|
|
GB201916030D0
|
|
Method of detecting or monitoring minimal residual disease
|
|
GB201915946D0
|
|
Quantitation of immunoglobulins i n mass spectrometry
|
|
GB201911605D0
|
|
Mass Spectrometry Controls
|
|
GB201910697D0
|
|
Lonisation control
|
|
GB201910708D0
|
|
Mass spectrometry calibrator
|
|
GB201906599D0
|
|
Mass spectrometry calibrator
|
|
GB201813736D0
|
|
Mass spectrometry controls
|
|
GB201808529D0
|
|
Identification of immunoglobulins usong mass spectrometry
|
|
GB201708262D0
|
|
Assay for plasma cell associated disease
|
|
CN102906569A
|
|
FLC as biomarker
|
|
GB201003485D0
|
|
Kidney prognostic assay
|
|
EP2238456A1
|
|
Cell staining assay and kit
|
|
EP2306202A1
|
|
Method of detecting or monitoring a malignant plasma cell disease
|
